Development of a natural transmission model of COVID-19
- Funded by Department of Health and Social Care / National Institute for Health and Care Research (DHSC-NIHR), UK Research and Innovation (UKRI)
- Total publications:3 publications
Grant number: MR/V036963/1
Grant search
Key facts
Disease
COVID-19Start & end year
20202021Known Financial Commitments (USD)
$260,069.16Funder
Department of Health and Social Care / National Institute for Health and Care Research (DHSC-NIHR), UK Research and Innovation (UKRI)Principal Investigator
Dr. Stuart DowallResearch Location
United KingdomLead Research Institution
Department of Health and Social CareResearch Priority Alignment
N/A
Research Category
Pathogen: natural history, transmission and diagnostics
Research Subcategory
Disease models
Special Interest Tags
N/A
Study Type
Non-Clinical
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Not Applicable
Vulnerable Population
Not applicable
Occupations of Interest
Not applicable
Abstract
For the assessment of interventions against COVID-19, there are currently no alternatives to the use of animal systems that fully recapitulate a whole functioning body system. The initial focus on in vivo models for COVID-19, based on experiences of establishing animal models for the pathogenic coronaviruses which cause SARS and MERS, were with ferret and non-human primate models. However, recent results from international laboratories working on SARS-CoV-2 have highlighted that hamsters show a more distinctive COVID19 disease with clinical signs associated with respiratory infection (rapid breathing, weight loss, ruffled fur). In addition to the clinical signs, hamsters have also been shown to shed SARS-CoV-2 and infect their naïve cage mates. Developing the means of establishing and investigating this natural challenge model will provide important and beneficial testing protocols that can be used evaluate prophylactic therapies and vaccines via a natural infection route under experimental conditions, within a carefully controlled containment level 3 (CL3) envelope. This capability will also enable investigations on transmissibility between animals and studies on different strains, including those SARS-CoV-2 viruses that may be engineered by molecular virology techniques to address questions on virus host interactions. Hamsters appear to offer a valuable disease model for COVID-19. Importantly, establishing the hamster model and associated techniques to evaluate interventions in the UK at the unique CL3 facilities of PHE-Porton, will also support a rapid intervention screening and in vivo research hub for the country on COVID-19. This will support UK industry and academia's research need's and evidence base to progress into clinical trials
Publicationslinked via Europe PMC
Last Updated:6 days ago
View all publications at Europe PMC